Refractory B Lymphoblastic Lymphoma: Clinical Trials

3 trials for Refractory B Lymphoblastic Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 withdrawn. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 2, Withdrawn 1
Phase 11Active not recruiting 1

Follow Refractory B Lymphoblastic Lymphoma: new trials by email Literature Review of Refractory B Lymphoblastic Lymphoma trials Research Report on Refractory B Lymphoblastic Lymphoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia
Biospecimen Collection, Computed Tomography, Lumbar Puncture - Recurrent Adult Lymphoblastic Lymphoma, Recurrent B Acute Lymphoblastic Leukemia
Phase 1 / Phase 2Active not recruitingECOG-ACRIN Cancer Research Group402018-08-132026-10-06
Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Asparaginase, Cyclophosphamide, Doxorubicin Hydrochloride - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 2WithdrawnUniversity of Washington2018-07-012018-11-14
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Bone Marrow Aspiration and Biopsy - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 2Active not recruitingChildren's Oncology Group802017-06-192026-10-01

Narrower conditions

Burkitt Lymphoma (3)  ·  Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (3)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Lymphoma (1)

Broader conditions

DNA Virus Infections (3)  ·  Epstein-Barr Virus Infections (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Herpesviridae Infections (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Infections (3)  ·  Leukemia (3)  ·  Leukemia, Lymphoid (3)  ·  Lymphatic Diseases (3)  ·  Lymphoma, B-Cell (3)  ·  Lymphoma, Non-Hodgkin (3)  ·  Lymphoproliferative Disorders (3)  ·  Neoplasms (3)

Interventions

Vincristine (3)  ·  Asparaginase (2)  ·  Cyclophosphamide (2)  ·  Specimen Handling (2)  ·  Spinal Puncture (2)  ·  Biopsy (1)  ·  Cytarabine (1)  ·  Doxorubicin (1)  ·  Etoposide (1)  ·  Imatinib Mesylate (1)  ·  Inotuzumab Ozogamicin (1)  ·  Leucovorin (1)  ·  Leyk (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Methotrexate (1)

Sponsors

Children's Oncology Group (1)  ·  ECOG-ACRIN Cancer Research Group (1)  ·  University of Washington (1)

Countries

United States (3)  ·  Puerto Rico (2)

Top investigators

Maureen M O'Brien (1)  ·  Neil D Palmisiano (1)  ·  Ryan Cassaday (1)

Results publications

PMID 35007127, PMID 35622074, PMID 39415930, PMID 41671463

NIH funding

P30CA015704 (1), U10CA180820 (1), U10CA180886 (1)